For example, a cardiology study comparing tPA to streptokinase/heparin after myocardial infarct included 41,021 patients and demonstrated p < 0.001 favoring tPA, despite having an absolute improvement in survival of only 1% [159]. This evidence concerns the gene PLAT and myocardial infarction.